Litcius/Paper detail

Anti–Phospholipase A2 Receptor 1 and Anti–Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort Study

Piero Ruggenenti, Linda Reinhard, Barbara Ruggiero, Annalisa Perna, Luca Perico, Tobia Peracchi, Diego Fidone, Alessia Gennarini, Ariela Benigni, Monica Cortinovis, Elion Hoxha, Giuseppe Remuzzi

2023American Journal of Kidney Diseases14 citationsDOIOpen Access PDF

Topics & Concepts

MedicineMembranous nephropathyRituximabAntibodyImmunologyProspective cohort studyInternal medicineGlomerulonephritisKidneyRenal Diseases and GlomerulopathiesChronic Kidney Disease and DiabetesBiomedical Research and Pathophysiology
Anti–Phospholipase A2 Receptor 1 and Anti–Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort Study | Litcius